UPS (UPS) will have doubled its health-care facilities footprint by 2023, as a result of unprecedented demand for mRNA vaccines, and the company is making a long-term bet that demand for cold chain storage in medicine will only grow in coming years. The logistics giant began building out millions of square feet of space as a result of its partnership with Pfizer (PFE)/ BioNTech (BNTX), according to UPS Healthcare and Life Sciences President Wes Wheeler, but that only sped up a strategy the… Source link
Read More »Alzheimer’s-like changes found in COVID patients’ brains; flu shot, mRNA booster safe together
By Nancy Lapid (Reuters) – The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review. Alzheimer’s-like changes seen in COVID-19 patients’ brains People who die of severe COVID-19 have brain abnormalities that resemble changes seen in Alzheimer’s disease – accumulation of a protein called tau inside brain cells, and abnormal amounts of the protein beta-amyloid that… Source link
Read More »‘It’s game over. It’s mRNA or nothing:’ Expert on future of vaccines
Pfizer (PFE) and its partner BioNTech (BNTX) recently got FDA full approval for the most widely-approved and sought after COVID-19 vaccine in the world, to date. It signals an important change in how vaccines of the future could look, according to Arnaud Bernaert, formerly head of Global Health and Healthcare at the World Economic Forum. Bernaert, now head of Health Security Solutions at Swiss-based SICPA, told Yahoo Finance, “I think it’s game over. I think it’s mRNA or nothing. [Other… Source link
Read More »Moderna, BioNTech Plunge As EU Studies Possible Side-effects Of mRNA Shots
By Dhirendra Tripathi Investing.com – Moderna (NASDAQ:MRNA) and BioNTech stocks (NASDAQ:BNTX) slumped by 15% each Wednesday on a report that Europe’s drug regulator is studying three new conditions reported by a small number of people after vaccination with Covid-19 shots to assess if they may be possible side-effects. The conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer. Pfizer stock fell 3%. Expenses and profit from the Covid… Source link
Read More »BioNTech to build mRNA vaccine manufacturing site in Singapore – Yahoo Tech
TipRanks 3 Monster Growth Stocks That Are Still Undervalued A lackluster jobs report didn’t derail the markets last week. New jobs in April totaled only 266,000, far below the 978K expected, and the official unemployment rate, which had been predicted to come in at 5.8% actually ticked up slightly to 6.1%. Even so, the tech-weighted NASDAQ gained 0.88% in Friday’s session, the broader S&P 500 was up 0.75% at the end of the day. These gains brought the S&P to a new record level, with a… Source link
Read More »mRNA vaccines spark innovation in logistics: Expert
The ultra-low temperature demands of the Pfizer (PFE) and BioNTech (BNTX) vaccine are paving a new path for vaccine delivery and storage. While mRNA vaccines requires a smaller footprint for production than traditional vaccines, once they leave the production plant, there’s a whole new set of hurdles prompting logistics companies to adapt. Planes have been retrofitted, GPS tracking has been authorized by the FAA, and states are buying large-volume freezers to meet the first generation of… Source link
Read More »